Difference between revisions of "Team:Munich/Software/Collaborations"

Line 119: Line 119:
 
</p>
 
</p>
 
<div class="captionPicture" align=center>
 
<div class="captionPicture" align=center>
<img alt="LightbringerReal" src="https://static.igem.org/mediawiki/2017/b/bf/T--Munich--SoftwareCollaborationsPagePicture-mfe.png" width="200">
+
<img alt="LightbringerReal" src="https://static.igem.org/mediawiki/2017/b/bf/T--Munich--SoftwareCollaborationsPagePicture-mfe.png" width="500">
 
<p>
 
<p>
 
<i>Figure 1: Graphical output of the secondary structure prediction of crRNA 2 in NUPACK.
 
<i>Figure 1: Graphical output of the secondary structure prediction of crRNA 2 in NUPACK.
Line 125: Line 125:
 
</div>
 
</div>
 
<div class="captionPicture" align=center>
 
<div class="captionPicture" align=center>
<img alt="LightbringerReal" src="https://static.igem.org/mediawiki/2017/c/c9/T--Munich--SoftwareCollaborationsPagePicture-activity.png" width="200">
+
<img alt="LightbringerReal" src="https://static.igem.org/mediawiki/2017/c/c9/T--Munich--SoftwareCollaborationsPagePicture-activity.png" width="500">
 
<p>
 
<p>
 
<i>Figure 2: Cleavage experiments of crRNA 2, crRNA 3 and crRNA 4 as provided by TU Delft.
 
<i>Figure 2: Cleavage experiments of crRNA 2, crRNA 3 and crRNA 4 as provided by TU Delft.
Line 191: Line 191:
  
 
<div class="captionPicture" align=center>
 
<div class="captionPicture" align=center>
<img alt="LightbringerReal" src="https://static.igem.org/mediawiki/2017/4/40/T--Munich--SoftwareCollaborationsPagePicture-cleavage.png" width="200">
+
<img alt="LightbringerReal" src="https://static.igem.org/mediawiki/2017/4/40/T--Munich--SoftwareCollaborationsPagePicture-cleavage.png" width="700">
 
<p>
 
<p>
 
<i>Figure 3: Off-target probability of activation of the Cas13a protein for our crRNAs sensing <i>E.Coli (1.3)</i> and <i>B. subtillis</i>.
 
<i>Figure 3: Off-target probability of activation of the Cas13a protein for our crRNAs sensing <i>E.Coli (1.3)</i> and <i>B. subtillis</i>.

Revision as of 06:07, 1 November 2017


Software Collaboration

For TU Delft

We started collaborating early after the European iGEM Meet-Up with TU Delft in the wetlab. Since we were both employing Cas13a as the molecular heart of our project, it made sense to exchange data and experiences from wet lab experiments. At some point during a skype meeting, we then realised that we were doing similar things in the dry lab as well and, thus, decided to start collaborating and exchanging in that field as well.

Secondary Structure Prediction

In our drylab collaboration with Team Delft, we performed a Cas13a design verification of crRNAs they used in their project with our developed software. Since the secondary structure of the crRNA is essential for its affinity to Cas13a, one can make assumptions on RNase activity of the protein after binding based on secondary structure predictions. We then proceed to compare these structures to secondary structures of crRNAs that have been shown to work experimentally. For the five crRNA sequences Team Delft provided, the predicted secondary structure matched one of the secondary structures in our databank. The only one that was not recognized by neither in the NUPACK nor the mFOLD databank was crRNA 2. Its predicted secondary structure in Vienna notation is depicted below:

GGAUUUAGACUACCCCAAAAACGAAGGGGACUAAAACAAGACAGUCAUAAGUGCGGCGACGAU
..(((((((((.((((.........)))).((......))..)))).))))).((....))..
It looks like the backbone structure needed in the first 35 bases is not constructed completely. When looking at the graphical output of NUPACK depicted in Figure 1, however, it is visible that the binding probability seems to be rather low regarding the structures that interact with the terminal 28 bp target sequence. Thus, crRNA 2 would most probably still be active when tested in experiment, but might show decreased activity.

LightbringerReal

Figure 1: Graphical output of the secondary structure prediction of crRNA 2 in NUPACK.

LightbringerReal

Figure 2: Cleavage experiments of crRNA 2, crRNA 3 and crRNA 4 as provided by TU Delft.

Indeed, decreased activity using crRNA 2 in comparison to other crRNA is observed when performing experiments using these crRNA designs. Though this has to be treated with caution since crRNA 4's secondary structure was predicted to be correct but the Cas13a-crRNA-complex with that crRNA does not show higher activity. We conclude that further testing of the software has to be done to show whether it can predict activity of Cas13a.

Off-target Effects

Furthermore, in order to determine off-target effects, we constructed a database from Transcriptome data obtained from the Ensembl and EnsemblBacteria databank. We tried to make the search as tailor-made to the Delft project as possible and thus considered species that were relevant to their project of detecting bacterial resistances related to cattle and milk production. The included species were:

  1. Bos Taurus (Cattle)
  2. Clostridium perfringens
  3. Corynebacterium diphtheria
  4. Fusobacterium necrophorum
  5. Lactobacillus casei
  6. Lactococcus lactis
  7. Providencia stuartii
  8. Staphylococcus aureus
  9. Streptococcus pneumoniae

Three of the five crRNAs showed no off-targets in the constructed database. For crRNA 3 and crRNA 4, possible off-targets were detected but just as a result of the identity parameter being rather low in the BLAST-short run. When looking at the results, it is clearly visible that the sequences are not identical enough to show any RNase activity of Cas13a since the 28 bases target is specific to up to 2 mutations, but all the hits that have been found are with a match of 17 bases far from the 28 bases long.

Finally, we can conclude that our software did not find any problems in the crRNA design of Team Delft. It seems that their constructs will most probably show activity and, at least for the mentioned species, it will not show any off-target effects.

From TU Delft

The TU Delft team developed a simulation a simulation code for modeling the on and off-target activities for sequences on all possible frames on the genome. In this, they employ a kinetic model by Depken et al. in 2017 to determine whether off-target activities are high enough to give a false positive collateral RNase activity of the Cas13a protein. They deducted from these model cleavage probabilities for different crRNA sequences and could thus make statements of the possibility to distinguish between our two bacterial targets, the 16s rRNA of E. Coli and B. subtillis. By running the crRNA against both genomes of these species, they determined the off-target probability to be very low for all our crRNA design as shown in Figure 3. Thus, they deduced from these that our crRNA design would be able to differentiate between E. Coli and B. subtilis.

LightbringerReal

Figure 3: Off-target probability of activation of the Cas13a protein for our crRNAs sensing E.Coli (1.3) and B. subtillis. crRNA 1-3 are taken into one since the spacer sequence of the crRNA was identical for these constructs.



We would like to thank Team Delft for the fun collaboration and them all the best for their projects. We are looking forward to seeing them in Boston.

References

  1. Klein, M., Eslami-Mossallam, B., Gonzalez Arroyo, D., Depken, M. (2017). "The kinetic basis of CRISPR-Cas off-targeting rules." doi: 10.1101/143602.